Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, and its line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical Products, Thoracolumbar Products, Sacroiliac Joint Products, Interbody Products and Interlaminar Stabilization Products.
BörsenkürzelXTNT
Name des UnternehmensXtant Medical Holdings Inc
IPO-datumJun 30, 2010
CEOMr. Sean E. Browne
Anzahl der mitarbeiter217
WertpapierartOrdinary Share
GeschäftsjahresendeJun 30
Addresse664 Cruiser Lane
StadtBELGRADE
BörseNYSE American Consolidated
LandUnited States of America
Postleitzahl59714
Telefon14063880480
Websitehttps://xtantmedical.com/
BörsenkürzelXTNT
IPO-datumJun 30, 2010
CEOMr. Sean E. Browne
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten